Live from the NIH registry
Studies recruiting near Mesa right now
Top 25 of 1,367 recruiting studies, sorted by proximity — each links to its official registry page
Shared Decision Making to Improve Goals of Care in the ED
Goals
N/A
Interventional 230 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (12.8 mi)
· Sponsor: Mayo Clinic
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (20.8 mi)
· Sponsor: National Cancer Institute (NCI)
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 200 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (12.8 mi)
· Sponsor: Mayo Clinic
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
Bone Graft; Complications, ACL Injuries
N/A
Interventional 75 participants sought
Banner Sports Medicine Scottsdale — Scottsdale, Arizona (12.8 mi)
· Sponsor: University of Arizona
Early Tracking of Childhood Health Determinants (ETCHED) Study
Diabetes Mellitus, Obesity
N/A
Observational 1,500 participants sought
NIDDK, Phoenix — Phoenix, Arizona (20.8 mi)
· Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 — Phoenix, Arizona (20.8 mi)
· Sponsor: Sanofi
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (20.8 mi)
· Sponsor: Rejoni Inc.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Ironwood Cancer & Research Centers — Chandler, Arizona (9.7 mi)
· Sponsor: Guardant Health, Inc.
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Colorectal Carcinoma
N/A
Interventional 450 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (12.8 mi)
· Sponsor: Mayo Clinic
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Phoenix, Arizona (20.8 mi)
· Sponsor: AstraZeneca
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (20.8 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Center at Saint Joseph's — Phoenix, Arizona (20.8 mi)
· Sponsor: SWOG Cancer Research Network
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Barrow Neurological Institute at St. Joseph's Hospital — Phoenix, Arizona (20.8 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Banner MD Anderson Cancer Center — Gilbert, Arizona (5.3 mi)
· Sponsor: Relay Therapeutics, Inc.
Light Exposure, Migraine Outcomes, and Sleep Quality
Migraine Headache, Sleep
N/A
Interventional 20 participants sought
ASU DeSmart Lab — Tempe, Arizona (11.1 mi)
· Sponsor: Arizona State University
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring, Fragility Fracture
N/A
Interventional 48 participants sought
University of Arizona — Phoenix, Arizona (20.8 mi)
· Sponsor: University of Southern California
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Mayo Clinic Arizona — Scottsdale, Arizona (12.8 mi)
· Sponsor: Tr1X, Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Mayo Clinic Hospital in Arizona — Phoenix, Arizona (20.8 mi)
· Sponsor: NRG Oncology
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Gilbert, Arizona (5.3 mi)
· Sponsor: Pfizer
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome
N/A
Interventional 2,000 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (12.8 mi)
· Sponsor: Mayo Clinic
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Advanced Liver Cancer
Phase 1
Interventional 200 participants sought
Mayo Clinic — Phoenix, Arizona (20.8 mi)
· Sponsor: Abbisko Therapeutics Co, Ltd
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Phoenix Cardiovascular Research Group — Phoenix, Arizona (20.8 mi)
· Sponsor: Biosense Webster, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Mayo Clinic — Scottsdale, Arizona (12.8 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Barnet Dulaney Perkins Eye Center — Mesa, Arizona (6.2 mi)
· Sponsor: Genentech, Inc.